AUSTRALIA-WIDE LOW FLAT RATE $9.90

Close Notification

Your cart does not contain any items

$146

Hardback

Not in-store but you can order this
How long will it take?

QTY:

English
Churchill Livingstone
28 July 2024
In this issue of Heart Failure Clinics, guest editors Drs. Giuseppe Limongelli, Michele Emdin, Marco Merlo, and Claudio Rapezzi bring their considerable expertise to the topic of Amyloid

Cardiomyopathies: Clinical, Diagnostic and Therapeutic Aspects. Top experts in the field discuss the role of clinical use of biomarkers in cardiac amyloidosis; cardiac magnetic resonance in the management of cardiac amyloidosis; bone scintigraphy: strength points and pitfalls in the diagnosis of ATTR-cardiac amyloidosis; PET and cardiac amyloidosis; endomyocardial biopsy in the diagnosis of cardiac amyloidosis; and much more.

Contains 17 relevant, practice-oriented topics including the changing epidemiology of cardiac amyloidosis; arrhythmic stratification of cardiac amyloidosis: state of the art; specific therapy in ATTR-related cardiomyopathy: future perspectives beyond tafamidis; and more. Provides in-depth clinical reviews on amyloid cardiomyopathies, offering actionable insights for clinical practice. Presents the latest information on this timely, focused topic under the leadership of experienced editors in the field. Authors synthesize and distill the latest research and practice guidelines to create clinically significant, topic-based reviews.
Edited by:   , , , , , , , , , , , , , , , , , , , , ,
Imprint:   Churchill Livingstone
Country of Publication:   United Kingdom
Dimensions:   Height: 254mm,  Width: 178mm, 
Weight:   450g
ISBN:   9780443121432
ISBN 10:   0443121435
Series:   The Clinics: Internal Medicine
Pages:   240
Publication Date:  
Audience:   Professional and scholarly ,  Undergraduate
Format:   Hardback
Publisher's Status:   Active
Amyloidosis and Amyloidogenesis: One Name, Many Diseases Pathophysiology of Cardiac Amyloidosis The Role of Echocardiography for the Clinical Diagnosis, Risk Stratification, and Management of Cardiac Amyloidosis Clinical Use of Biomarkers in Cardiac Amyloidosis Cardiovascular Magnetic Resonance in the Management of Cardiac Amyloidosis: Current and Future Clinical Applications The Role of Scintigraphy with Bone Radiotracers in Cardiac Amyloidosis Genotype-Phenotype Correlations in ATTR Amyloidosis: A Clinical Update Standard Therapy in Cardiac Amyloidosis: What is Known, What is “Gray” Tafamidis in the Treatment of ATTR-related Cardiomyopathy: Indications and Grey Zones Specific Therapy in Transthyretin Amyloid Cardiomyopathy: Future Perspectives Beyond Tafamidis

See Also